Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1990 1
1991 1
1992 3
1997 1
1998 1
2001 3
2002 1
2004 1
2005 1
2006 3
2007 3
2008 5
2009 5
2010 10
2011 12
2012 6
2013 17
2014 29
2015 30
2016 35
2017 54
2018 49
2019 44
2020 44
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 25160934

326 results
Results by year
Filters applied: . Clear all
Page 1
Identification of antibody glycosylation structures that predict monoclonal antibody Fc-effector function.
Chung AW, Crispin M, Pritchard L, Robinson H, Gorny MK, Yu X, Bailey-Kellogg C, Ackerman ME, Scanlan C, Zolla-Pazner S, Alter G. Chung AW, et al. AIDS. 2014 Nov 13;28(17):2523-30. doi: 10.1097/QAD.0000000000000444. AIDS. 2014. PMID: 25160934 Free PMC article.
Monoclonal Antibodies Specific for the V2, V3, CD4-Binding Site, and gp41 of HIV-1 Mediate Phagocytosis in a Dose-Dependent Manner.
Musich T, Li L, Liu L, Zolla-Pazner S, Robert-Guroff M, Gorny MK. Musich T, et al. J Virol. 2017 Mar 29;91(8):e02325-16. doi: 10.1128/JVI.02325-16. Print 2017 Apr 15. J Virol. 2017. PMID: 28122974 Free PMC article.
Fc-glycosylation influences Fcγ receptor binding and cell-mediated anti-HIV activity of monoclonal antibody 2G12.
Forthal DN, Gach JS, Landucci G, Jez J, Strasser R, Kunert R, Steinkellner H. Forthal DN, et al. J Immunol. 2010 Dec 1;185(11):6876-82. doi: 10.4049/jimmunol.1002600. Epub 2010 Nov 1. J Immunol. 2010. PMID: 21041724 Free article.
Control of recombinant monoclonal antibody effector functions by Fc N-glycan remodeling in vitro.
Hodoniczky J, Zheng YZ, James DC. Hodoniczky J, et al. Biotechnol Prog. 2005 Nov-Dec;21(6):1644-52. doi: 10.1021/bp050228w. Biotechnol Prog. 2005. PMID: 16321047
Characterizing the effect of multiple Fc glycan attributes on the effector functions and FcγRIIIa receptor binding activity of an IgG1 antibody.
Pace D, Lewis N, Wu T, Gillespie R, Leiske D, Velayudhan J, Rohrbach A, Connell-Crowley L. Pace D, et al. Biotechnol Prog. 2016 Sep;32(5):1181-1192. doi: 10.1002/btpr.2300. Epub 2016 Jun 7. Biotechnol Prog. 2016. PMID: 27160519
Multi-Angle Effector Function Analysis of Human Monoclonal IgG Glycovariants.
Dashivets T, Thomann M, Rueger P, Knaupp A, Buchner J, Schlothauer T. Dashivets T, et al. PLoS One. 2015 Dec 11;10(12):e0143520. doi: 10.1371/journal.pone.0143520. eCollection 2015. PLoS One. 2015. PMID: 26657484 Free PMC article.
Multiplexed Fc array for evaluation of antigen-specific antibody effector profiles.
Brown EP, Dowell KG, Boesch AW, Normandin E, Mahan AE, Chu T, Barouch DH, Bailey-Kellogg C, Alter G, Ackerman ME. Brown EP, et al. J Immunol Methods. 2017 Apr;443:33-44. doi: 10.1016/j.jim.2017.01.010. Epub 2017 Feb 3. J Immunol Methods. 2017. PMID: 28163018 Free PMC article.
An engineered Fc variant of an IgG eliminates all immune effector functions via structural perturbations.
Vafa O, Gilliland GL, Brezski RJ, Strake B, Wilkinson T, Lacy ER, Scallon B, Teplyakov A, Malia TJ, Strohl WR. Vafa O, et al. Methods. 2014 Jan 1;65(1):114-26. doi: 10.1016/j.ymeth.2013.06.035. Epub 2013 Jul 17. Methods. 2014. PMID: 23872058
Crystal structure of a novel asymmetrically engineered Fc variant with improved affinity for FcγRs.
Mimoto F, Kadono S, Katada H, Igawa T, Kamikawa T, Hattori K. Mimoto F, et al. Mol Immunol. 2014 Mar;58(1):132-8. doi: 10.1016/j.molimm.2013.11.017. Epub 2013 Dec 14. Mol Immunol. 2014. PMID: 24334029 Free article.
Structural characterization of GASDALIE Fc bound to the activating Fc receptor FcγRIIIa.
Ahmed AA, Keremane SR, Vielmetter J, Bjorkman PJ. Ahmed AA, et al. J Struct Biol. 2016 Apr;194(1):78-89. doi: 10.1016/j.jsb.2016.02.001. Epub 2016 Feb 2. J Struct Biol. 2016. PMID: 26850169 Free PMC article.
326 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page